Pharma major Lupin Ltd said that it has received final approval from the USFDA to market a pain relief drug.
“Lupin received final approval for its Oxycodone and Acetaminophen Tablets USP, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg from the United States Food and Drug Administration (FDA) to market a generic version of Vintage Pharmaceuticals LLC's Percocet tablets,” the company said in a filing to the Bombay Stock Exchange.
The approved product is indicated for relief of moderate to moderately severe pain. Percocet tablets had US sales of USD 838.7 million.
Lupin said it will commence promoting the product shortly.
Meanwhile, shares of the company were trading at Rs 1471.10 apiece, up 0.50 per cent from the previous close at 13:05 hours on BSE.